VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,304,970 | +58.9% | 791,712 | +77.8% | 0.06% | +37.5% |
Q2 2023 | $13,404,340 | -31.9% | 445,179 | -26.8% | 0.04% | -4.8% |
Q1 2023 | $19,684,425 | +89.2% | 608,483 | +67.6% | 0.04% | +40.0% |
Q4 2022 | $10,404,411 | -7.6% | 363,029 | -22.3% | 0.03% | -11.8% |
Q3 2022 | $11,264,000 | +91.3% | 467,030 | +117.2% | 0.03% | +78.9% |
Q2 2022 | $5,889,000 | -42.4% | 215,063 | -19.3% | 0.02% | -40.6% |
Q1 2022 | $10,223,000 | +20.4% | 266,580 | +0.5% | 0.03% | +10.3% |
Q4 2021 | $8,494,000 | -26.3% | 265,187 | -32.2% | 0.03% | -29.3% |
Q3 2021 | $11,524,000 | +59.3% | 391,050 | +83.7% | 0.04% | +41.4% |
Q2 2021 | $7,234,000 | +43.8% | 212,871 | +37.6% | 0.03% | +31.8% |
Q1 2021 | $5,029,000 | -67.7% | 154,719 | -64.2% | 0.02% | -67.6% |
Q4 2020 | $15,579,000 | -35.4% | 432,497 | -29.7% | 0.07% | -46.9% |
Q3 2020 | $24,101,000 | +156.1% | 615,462 | +139.9% | 0.13% | +113.3% |
Q2 2020 | $9,411,000 | +40.0% | 256,571 | -12.1% | 0.06% | +17.6% |
Q1 2020 | $6,723,000 | -62.0% | 291,790 | -51.7% | 0.05% | -58.2% |
Q4 2019 | $17,676,000 | +135.8% | 603,663 | +115.1% | 0.12% | +90.6% |
Q3 2019 | $7,495,000 | -43.7% | 280,600 | -46.1% | 0.06% | -44.3% |
Q2 2019 | $13,317,000 | -6.4% | 521,000 | -17.9% | 0.12% | +3.6% |
Q1 2019 | $14,229,000 | -38.5% | 634,619 | -42.2% | 0.11% | -34.7% |
Q4 2018 | $23,149,000 | +124.7% | 1,097,641 | +97.3% | 0.17% | +209.1% |
Q3 2018 | $10,302,000 | +59.2% | 556,251 | +91.8% | 0.06% | +57.1% |
Q2 2018 | $6,470,000 | -59.2% | 290,030 | -59.8% | 0.04% | -61.5% |
Q1 2018 | $15,857,000 | +64.9% | 721,405 | +74.3% | 0.09% | +93.6% |
Q4 2017 | $9,619,000 | -23.7% | 413,800 | -24.6% | 0.05% | -25.4% |
Q3 2017 | $12,607,000 | +82.8% | 548,994 | +75.5% | 0.06% | +50.0% |
Q2 2017 | $6,897,000 | +39.0% | 312,781 | +43.8% | 0.04% | +20.0% |
Q1 2017 | $4,962,000 | +2.7% | 217,450 | -6.0% | 0.04% | +2.9% |
Q4 2016 | $4,833,000 | -62.1% | 231,221 | -52.1% | 0.03% | -59.0% |
Q3 2016 | $12,763,000 | +88.4% | 482,700 | +97.6% | 0.08% | +88.6% |
Q2 2016 | $6,773,000 | – | 244,281 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |